Literature DB >> 6876078

Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline.

R D Titus, E C Kornfeld, N D Jones, J A Clemens, E B Smalstig, R W Fuller, R A Hahn, M D Hynes, N R Mason, D T Wong, M M Foreman.   

Abstract

The title compound (+/-)-5 (R = Pro) (LY141865) has been resolved into a (-) isomer and a (+) isomer as the D- and L-tartrate salts, respectively. Biological studies have shown that dopamine agonist activity is a property of only the (-) isomer. Crystallographic analysis has proven that the absolute configuration of the active (-) isomer is the same as that of the natural ergolines.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6876078     DOI: 10.1021/jm00362a005

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

1.  Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.

Authors:  S Ahlenius; V Hillegaart; A Wijkström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

2.  Modulation of inhibitory transmission by dopamine in rat basal forebrain nuclei: activation of presynaptic D1-like dopaminergic receptors.

Authors:  T Momiyama; J A Sim
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

3.  Dopaminergic control of transmission from group II muscle afferents to spinal neurones in the cat and guinea-pig.

Authors:  B Skoog; B R Noga
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

4.  Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon the behavioural satiety sequence.

Authors:  G D Phillips; S R Howes; R B Whitelaw; T W Robbins; B J Everitt
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

5.  Nicotine modulation of adolescent dopamine receptor signaling and hypothalamic peptide response.

Authors:  Celina Y Mojica; Jasmin M Dao; Menglu Yuan; Sandra E Loughlin; Frances M Leslie
Journal:  Neuropharmacology       Date:  2013-10-22       Impact factor: 5.250

6.  Dopamine D1-like receptor-mediated presynaptic inhibition of excitatory transmission onto rat magnocellular basal forebrain neurones.

Authors:  T Momiyama; J A Sim; D A Brown
Journal:  J Physiol       Date:  1996-08-15       Impact factor: 5.182

7.  Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.

Authors:  J Arnt; J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat.

Authors:  S O Ogren; J Lundström; L B Nilsson; M Widman
Journal:  J Neural Transm Gen Sect       Date:  1993

9.  Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain.

Authors:  D T Wong; F P Bymaster; L R Reid; R W Fuller; K W Perry; E C Kornfeld
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

10.  Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats.

Authors:  R W Fuller; S K Hemrick-Luecke
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.